Advanced Endometrial Cancer Not Yet Recruiting Phase 3 Trials for Lenvatinib (DB09078)

IndicationStatusPhase
DBCOND0050728 (Advanced Endometrial Cancer)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05077215Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial CancerTreatment